RCORP - Rural Center of Excellence on SUD Prevention

Search pages...

RCORP - Rural Center of Excellence on SUD Prevention

Search pages...

RCORP - Rural Center of Excellence on SUD Prevention

A Convenient Way to Connect: Videoconferencing Group Therapy

January 27, 2021

January 27, 2021

Articles
Articles

As Strong Recovery converted their groups for substance use disorder (SUD) to videoconferencing during COVID-19, they found this format was also more convenient for some patients: It helped with challenges around transportation and childcare and made some people feel more at ease.

Research on video-based group therapy suggests it can increase access to treatment for behavioral health, including in rural communities:

  • “Home-based videoconferencing groups overcame known barriers for attending face-to-face groups” including travel demands. They “could be used to develop new and relatively low-cost interventions, particularly with at-risk groups such as those living in rural areas.”¹

  • “Given the limited availability of mental health providers, especially in remote or rural areas, it is reasonable to consider group-based treatment [through telehealth] as a way to disseminate evidence-based care more broadly.”²

The Substance Abuse and Mental Health Services Administration (SAMHSA) describes barriers people in rural communities face in finding treatment and how telehealth can help offset them—with outcomes comparable to in-person treatment. SAMHSA’s guidance, summarized in the table below,³ points to the advantages of telehealth strategies like videoconferencing groups.

While video-based group therapy is the focus of this article series, telehealth can take a variety of forms as a tool in the treatment of SUD. It includes, for example, assessments and modules that can be used at any time as well as telephone-based therapy occurring in real time.⁴ When implementing social distancing, Strong Recovery quickly pivoted to telehealth by phone to provide individual therapy. Not dependent on internet or a video camera, this audio-only approach continues to be the most convenient type of telehealth for some patients. During COVID-19, federal agencies have provided flexibilities around telehealth. Medicaid and Medicare have adjusted their reimbursements for telehealth services including therapy by phone, for example, and use of certain video platforms that are not HIPAA compliant has been permitted. Providers should remain current on federal and state policies as well as third-party billing considerations as the landscape shifts during and after the pandemic.

Barriers in rural areas

Benefits of telehealth

Considerations

Fewer providers, treatment programs, and other services

Patients can connect with providers and services outside immediate area.

Providers knowledgeable about and engaged with the community

Licensing, data security and billing reimbursement may be complex.

Less access to evidence-based practices1

Access to evidence-based treatment not limited by geography


Travel demands and lack of transportation

Less need to travel for treatment; easier to go to appointments

Lack of broadband internet may be a barrier to home-based telehealth. Internet hotspots or use of telehealth suite—e.g., space at an office or hospital—may help. [See recommended resources below.]

Traveling for treatment creates additional challenges such as childcare

Fewer obstacles to attending treatment


Cost of care and lack of treatment programs that accept Medicaid

Potential to find lower-cost treatment and programs that accept Medicaid

Insurance coverage for telehealth is changing & needs to be monitored carefully.

Lack of privacy; concerns about being seen at treatment location

Treatment from home or telehealth suite can offer privacy.

HIPAA-compliant video platform should be used for telehealth.

Reluctance to seek treatment due to sense it wouldn’t be helpful, ethic of self-reliance, or other reasons

Telehealth is also a site where providers can educate themselves in order to provide culturally appropriate treatment.


 

Resources to help providers and patients with telehealth include:

  • Health Resources and Services Administration telehealth website and telehealth policy information

  • Rural Health Information Hub Rural Telehealth Toolkit

  • For broadband/internet, Universal Service Administrative Co.’s Lifeline program (individuals) or Rural Health Care program (providers and facilities)

  • Center for Connected Health Policy, which includes state policy information

For a full description of videoconferencing groups, see our main article.

References

[1] Banbury, A., Nancarrow, S., Dart, J., Gray, L., Parkinson, L. (2018). Telehealth interventions delivering home-based support group videoconferencing: Systematic review. Journal of Medical Internet Research, 20(2), e25. https://doi.org/10.2196/jmir.8090

[2] Gentry, M.T., Lapid, M.I., Clark, M.M., Rummans, T.A. (2018; 2019). Evidence for telehealth group-based treatment: A systematic review. Journal of Telemedicine and Telecare, 25(6), 327–342. https://doi.org/10.1177/1357633X18775855. Quotation is from the conclusion. 

[3] Substance Abuse and Mental Health Services Administration. (2016). Rural behavioral health: Telehealth challenges and opportunities. In Brief 9(2).

[4] A 2020 article from the Mayo Clinic reviews telehealth interventions for SUD treatment, placing them in the context of the COVID-19 pandemic, and suggests strategies for implementation. Oesterle, T.S., Kolla, B., Risma, C.J., Breitinger, S.A., Rakocevic, D.B., Loukianova, L.L., . . . Gold, M.S. (2020). Substance use disorders and telehealth in the COVID-19 pandemic era. Mayo Clinic Proceedings, 95(12), 2709-2718. https://doi.org/10.1016/j.mayocp.2020.10.011

This HRSA RCORP RCOE program is supported by the Health Resources & Services Administration (HRSA) of the US Department of Health & Human Services (HHS) as part of an award of $3.33M in the current year with 0% financed with non-governmental sources.

The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by HRSA, HHS or the US Government.

As the Rural Communities Opioid Response Program (RCORP)-Rural Center of Excellence on SUD Prevention, UR Medicine Recovery Center of Excellence provides access to a wide range of resources on relevant topics. Inclusion in this document does not imply endorsement of, or agreement with, the contents by UR Medicine Recovery Center of Excellence or HRSA.  

© Copyright 2025 University of Rochester Medical Center

This HRSA RCORP RCOE program is supported by the Health Resources & Services Administration (HRSA) of the US Department of Health & Human Services (HHS) as part of an award of $3.33M in the current year with 0% financed with non-governmental sources.

The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by HRSA, HHS or the US Government.

As the Rural Communities Opioid Response Program (RCORP)-Rural Center of Excellence on SUD Prevention, UR Medicine Recovery Center of Excellence provides access to a wide range of resources on relevant topics. Inclusion in this document does not imply endorsement of, or agreement with, the contents by UR Medicine Recovery Center of Excellence or HRSA.  

© Copyright 2025 University of Rochester Medical Center

This HRSA RCORP RCOE program is supported by the Health Resources & Services Administration (HRSA) of the US Department of Health & Human Services (HHS) as part of an award of $3.33M in the current year with 0% financed with non-governmental sources.

The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by HRSA, HHS or the US Government.

As the Rural Communities Opioid Response Program (RCORP)-Rural Center of Excellence on SUD Prevention, UR Medicine Recovery Center of Excellence provides access to a wide range of resources on relevant topics. Inclusion in this document does not imply endorsement of, or agreement with, the contents by UR Medicine Recovery Center of Excellence or HRSA.  

© Copyright 2025 University of Rochester Medical Center